Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. JAMA. 2021;325:1101–2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maltezou HC, Hatziantoniou S, Theodoridou K, Vasileiou K, Anastassopoulou C, Tsakris A. Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: analysis of data reported to eudravigilance. Vaccine. 2023;41:2382–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Risma KA, Edwards KM, Hummell DS, Little FF, Norton AE, Stallings A, et al. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines. J Allergy Clin Immunol. 2021;147:2075–82..e2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wimazal F, Geissler P, Shnawa P, Sperr WR, Valent P. Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: A single-center experience. Int Arch Allergy Immunol. 2011;157:399–405.

Article  PubMed  Google Scholar 

Jennings S, Russell N, Jennings B, Slee V, Sterling L, Castells M, et al. The mastocytosis society survey on mast cell disorders: patient experiences and perceptions. J Allergy Clin Immunol Pract. 2014;2:70–6.

Article  PubMed  Google Scholar 

Akin C, Valent P, Metcalfe DD. Mast cell activation syndrome: proposed diagnostic criteria. J Allergy Clin Immunol. 2010;126:1099–e11044.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonadonna P, Brockow K, Niedoszytko M, Elberink HO, Akin C, Nedoszytko B, et al. COVID-19 vaccination in mastocytosis: recommendations of the European competence network on mastocytosis (ECNM) and American initiative in mast cell diseases (AIM). J Allergy Clin Immunol Pract. 2021;9:2139–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giannetti MP, Olivieri F, Godwin G, Weller E, Nicoloro-SantaBarbara J, Bonadonna P et al. Outcomes of COVID‐19 vaccination in 323 patients with clonal and non‐clonal mast cell activation disorders. Allergy. 2022;10.1111/all.15476.

Rama TA, Miranda J, Silva D, Amaral L, Castro E, Coimbra A, et al. COVID-19 vaccination is safe among mast cell disorder patients, under adequate premedication. Vaccines. 2022;10:718.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lazarinis N, Bossios A, Gülen T. COVID-19 vaccination in the setting of mastocytosis—Pfizer-BioNTech mRNA vaccine is safe and well tolerated. J Allergy Clin Immunol Pract. 2022;10:1377–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sriskandarajah P, Hobart J, Radia DH, Whyte AF. A UK survey examining the experience of adults with mastocytosis Rceiving COVID-19 vaccination. HemaSphere. 2021;5:e650.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao Y-M, Xu G, Wang B, Liu B-C. Cytokine storm syndrome in coronavirus disease 2019: A narrative review. J Intern Med. 2021;289:147–61.

Article  CAS  PubMed  Google Scholar 

Fajgenbaum DC, June CH. Cytokine Storm. Longo DL, editor. N Engl J Med. 2020;383:2255–73.

Au L, Fendler A, Shepherd STC, Rzeniewicz K, Cerrone M, Byrne F, et al. Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2. Nat Med. 2021;27:1362–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boehm T, Ristl R, Mühlbacher J, Valent P, Wahrmann M, Jilma B. Massive release of TH2 cytokines induced a cytokine storm during a severe mast cell activation event in a patient with indolent systemic mastocytosis. J Allergy Clin Immunol. 2022;150:406–e41416.

Article  CAS  PubMed  Google Scholar 

Boehm T, Ristl R, Joseph S, Petroczi K, Klavins K, Valent P, et al. Metabolome and lipidome derangements during a severe mast cell activation event in a patient with indolent systemic mastocytosis. J Allergy Clin Immunol. 2021;148:1533–44.

Article  CAS  PubMed  Google Scholar 

McGrath AP, Hilmer KM, Collyer CA, Shepard EM, Elmore BO, Brown DE, et al. Structure and Inhibition of human Diamine oxidase. Biochemistry. 2009;48:9810–22.

Article  CAS  PubMed  Google Scholar 

Boehm T, Pils S, Gludovacz E, Szoelloesi H, Petroczi K, Majdic O, et al. Quantification of human Diamine oxidase. Clin Biochem. 2017;50:444–51.

Article  CAS  PubMed  Google Scholar 

Karer M, Rager-Resch M, Haider T, Petroczi K, Gludovacz E, Borth N et al. Diamine oxidase knockout mice are not hypersensitive to orally or subcutaneously administered Histamine. Inflamm Res. 2022;497–511.

Boehm T, Karer M, Gludovacz E, Petroczi K, Resch M, Schuetzenberger K, et al. Simple, sensitive and specific quantification of Diamine oxidase activity in complex matrices using newly discovered fluorophores derived from natural substrates. Inflamm Res. 2020;69:937–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crenn P, Coudray–Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology. 2000;119:1496–505.

Article  CAS  PubMed  Google Scholar 

Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA, et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI. Leuk Res. 2003;27:677–82.

Article  CAS  PubMed  Google Scholar 

Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res. 1988;12:345–55.

Article  CAS  PubMed  Google Scholar 

Boehm T, Reiter B, Ristl R, Petroczi K, Sperr W, Stimpfl T, et al. Massive release of the histamine-degrading enzyme Diamine oxidase during severe anaphylaxis in mastocytosis patients. Allergy. 2019;74:583–93.

Article  CAS  PubMed  Google Scholar 

Bochner BS, Charlesworth EN, Lichtenstein LM, Derse CP, Gillis S, Dinarello CA, et al. Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol. 1990;86:830–9.

Article  CAS  PubMed  Google Scholar 

Polukort SH, Rovatti J, Carlson L, Thompson C, Ser-Dolansky J, Kinney SRM, et al. IL-10 enhances IgE-mediated mast cell responses and is essential for the development of experimental food allergy in IL-10–deficient mice. J Immunol. 2016;196:4865–76.

Article  CAS  PubMed  Google Scholar 

Ochi H, De Jesus NH, Hsieh FH, Austen KF, Boyce JA. IL-4 and– 5 prime human mast cells for different profiles of IgE-dependent cytokine production. Proc Natl Acad Sci. 2000;97:10509–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Del Valle DM, Kim-Schulze S, Huang H-H, Beckmann ND, Nirenberg S, Wang B, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26:1636–43.

Article  PubMed  PubMed Central  Google Scholar 

Kang S, Tanaka T, Narazaki M, Kishimoto T. Targeting Interleukin-6 signaling in clinic. Immunity. 2019;50:1007–23.

Article  CAS  PubMed  Google Scholar 

Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the genetic and inflammatory markers of sepsis (GenIMS) study. Arch Intern Med. 2007;167:1655–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, et al. Effectiveness and safety of Tocilizumab: postmarketing surveillance of 7901 patients with rheumatoid arthritis in Japan. J Rheumatol. 2014;41:15–23.

Article  CAS  PubMed